Fertility-female
Conditions
Interventions
Insertion of copper T 360A
Sponsors
Makerere Unversity
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: • Postpartum women who will be willing to be followed up and give informed consent
Exclusion criteria
Exclusion criteria: • Intrapartum chorioamnionitis (defined as maternal fever >100.4 and two of the following conditions: Maternal leukocytosis (greater than 15,000 cells/cubic millimeter), Maternal tachycardia (greater than 100 beats/minute), Fetal tachycardia (greater than 160 beats/minute), Uterine tenderness, Foul odor of the amniotic fluid • Postpartum Hemorrhage (defined as >500cc EBL for spontaneous vaginal delivery or >1000cc for cesarean delivery) • Congenital or acquired uterine anomaly including fibroids if they distort the uterine cavity • Acute liver disease or liver tumor • Hypersensitivity to any component of the product • Known or suspected carcinoma of the breast • Current breast cancer or breast cancer within the past 5 years • Decompensated cirrhosis or a liver tumor • Known or suspected uterine or cervical neoplasia or unresolved, abnormal pap smear • Unexplained vaginal bleeding prior to pregnancy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Expulsion of copper T 380A and Levonorgetstrel intrauterine system | — |
Secondary
| Measure | Time frame |
|---|---|
| Discontinued of intrauterine contraceptives, Abnormal vaginal bleeding, Cramping, satisfaction with intrauterine contraception Post insertion sepsis and breastfeeding continuation over the 12 months. | — |
Countries
Uganda
Contacts
Public ContactPonsiano Ocama
Prof. Department of internal medicine MakCHS
Outcome results
None listed